The iShares Biotechnology ETF is up over 32% in six months on rate cut expectations and potential sector rotation. The State Street SPDR S&P Biotech ETF has surged 45% in six months but remains 27% ...

“Structured products” are proliferating in exchange-traded funds, and defined-outcome ETFs, or “buffer ETFs,” are among the most popular. These ETFs use options to provide an explicit amount of loss ...

Some growth ETFs are riskier than others, but all are designed to earn greater returns over the long term. From tech-focused funds to mega-cap growth ETFs, these investments can supercharge your ...

Vanguard ETFs have low fees, largely due to their unique investor-owned structure. They offer broad diversification and tax efficiency across a substantial ETF lineup. Vanguard's ETF selections cater ...

U.S.-listed exchange traded funds closed 2025 on a historic note, according to State Street’s latest fund flows report, as investors poured unprecedented amounts of capital into ETFs across asset ...